Trastuzumab (for HER2+ Adenocarcinoma)
Treatment used for 1 condition
Total Trials
15
Total Participants
3K
Avg Effectiveness
60%
Avg Safety Score
55%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.